Takeda subsidiary ordered to pay Bayer $182m after overturn bid fails

27-08-2019

Saman Javed

Takeda subsidiary ordered to pay Bayer $182m after overturn bid fails

Jonathan Weiss / Shutterstock.com

A Takeda subsidiary cannot overturn a $155 million jury verdict that it infringed one of Bayer’s patents, a district court has ruled.


Takeda, Baxalta, Bayer, hemophilia, patent infringement, US District Court for the District of Delaware

LSIPR